Literature DB >> 18542113

Mechanisms of heartburn.

Daphne Ang1, Daniel Sifrim, Jan Tack.   

Abstract

Heartburn is a typical symptom of GERD. The spectrum of diseases associated with GERD includes reflux esophagitis, Barrett's esophagus and nonerosive reflux disease (NERD). Although acid reflux is the classic cause of heartburn in patients with erosive esophagitis, the relationship between acid and heartburn is far from clear, especially in patients with NERD. Strong evidence exists that weakly acidic reflux and/or non-acid-related events have a significant role in the generation of heartburn. In addition to the role of nonacidic refluxate components, activation of mechanoreceptors and chemoreceptors, and a possible role for central and peripheral sensitization, has been described. Although patients with erosive esophagitis respond well to acid-suppressive therapy, the same does not hold true for those with NERD. NERD represents a major clinical problem, and its management remains a challenge. Discussion of NERD focuses on the mechanisms that cause chest pain in this subgroup of patients. Improved understanding of the pathogenesis underlying heartburn in patients with GERD, in particular those with NERD, will shape our understanding of this condition. Such understanding will serve as a platform for further research and allow additional therapies to be developed for this increasingly encountered clinical condition.

Entities:  

Mesh:

Year:  2008        PMID: 18542113     DOI: 10.1038/ncpgasthep1160

Source DB:  PubMed          Journal:  Nat Clin Pract Gastroenterol Hepatol        ISSN: 1743-4378


  16 in total

1.  Specific dyspeptic symptoms are associated with poor response to therapy in patients with gastroesophageal reflux disease.

Authors:  A D'Alessandro; F P Zito; M Pesce; P Andreozzi; E Efficie; M Cargiolli; F Maione; G D De Palma; R Cuomo; G Sarnelli
Journal:  United European Gastroenterol J       Date:  2016-07-07       Impact factor: 4.623

2.  Necrotizing sialometaplasia-like change of the esophageal submucosal glands is associated with Barrett's esophagus.

Authors:  David R Braxton; Dana C Nickleach; Yuan Liu; Alton B Farris
Journal:  Virchows Arch       Date:  2014-05-27       Impact factor: 4.064

Review 3.  Pathophysiology of Gastroesophageal Reflux Disease.

Authors:  Mariano A Menezes; Fernando A M Herbella
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

Review 4.  TRP channels in neurogastroenterology: opportunities for therapeutic intervention.

Authors:  Werend Boesmans; Grzegorz Owsianik; Jan Tack; Thomas Voets; Pieter Vanden Berghe
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

5.  Gastro-esophageal reflux disease: the recent trend in Japan.

Authors:  Hiroto Miwa; Tadayuki Oshima; Toshihiko Tomita; Yongmin Kim; Kazutoshi Hori; Takayuki Matsumoto
Journal:  Clin J Gastroenterol       Date:  2008-12-02

Review 6.  NERD: an umbrella term including heterogeneous subpopulations.

Authors:  Edoardo Savarino; Patrizia Zentilin; Vincenzo Savarino
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-26       Impact factor: 46.802

7.  Nonerosive Reflux Disease (NERD) - An Update.

Authors:  Tiberiu Hershcovici; Ronnie Fass
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

Review 8.  Contribution of immunomodulators to gastroesophageal reflux disease and its complications: stromal cells, interleukin 4, and adiponectin.

Authors:  Jing Li; Xiaoxin Luke Chen; Anisa Shaker; Tadayuki Oshima; Jing Shan; Hiroto Miwa; Cheng Feng; Jun Zhang
Journal:  Ann N Y Acad Sci       Date:  2016-07-21       Impact factor: 5.691

9.  Nrf2 deficiency impairs the barrier function of mouse oesophageal epithelium.

Authors:  Hao Chen; Yuhui Hu; Yu Fang; Zorka Djukic; Masayuki Yamamoto; Nicholas J Shaheen; Roy C Orlando; Xiaoxin Chen
Journal:  Gut       Date:  2013-05-15       Impact factor: 23.059

Review 10.  Cough and gastroesophageal reflux: insights from animal models.

Authors:  Marian Kollarik; Mariana Brozmanova
Journal:  Pulm Pharmacol Ther       Date:  2008-12-31       Impact factor: 3.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.